Graves' Orbitopathy
Showing 1 - 3 of 3
Thyroid Eye Disease, Graves' Orbitopathy Trial in Germany, Italy, United States (Teprotumumab, Placebo)
Completed
- Thyroid Eye Disease
- Graves' Orbitopathy
- Teprotumumab
- Placebo
-
Beverly Hills, California
- +13 more
Jan 31, 2022
Graves' Orbitopathy Trial in Pisa (Atorvastatin 20mg, Placebo)
Not yet recruiting
- Graves' Orbitopathy
- Atorvastatin 20mg
- Placebo
-
Pisa, ItalyOspedale Cisanello-Endocrinology II
Sep 8, 2021
Thyroid Eye Disease, Graves' Orbitopathy Trial in United States (Teprotumumab)
Approved for marketing
- Thyroid Eye Disease
- Graves' Orbitopathy
- Teprotumumab
-
Beverly Hills, California
- +7 more
Mar 13, 2020